Tradestie Institutional Equity Comparison Engine
RBOT.WS vs ALGN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ALGN Overall Edge
ALGN Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Align Technology Inc (ALGN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, RBOT.WS trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ALGN at 12.6x Forward P/E and 19.6% operating margin (+1.9% YoY). In options structure, RBOT.WS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ALGN sits in SURGE (10th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ALGN
RBOT.WS N/M vs ALGN 12.6x Fwd P/E
Growth & Margin Winner
ALGN
Op Margin N/A vs 19.6% ยท YoY N/A vs +1.9%
Momentum & Technical Winner
ALGN
1Y -67.2% vs +16.1% ยท 52W Pos 0% vs 34%
Options & Structure Winner
ALGN
UNCLASSIFIED (N/A IV) vs SURGE (10th %ile IV)
RBOT.WS
NYSE
Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.01
-24.77% 1D
Market Cap
N/A
1M Return
-67.2%
1Y Return
-67.2%
Forward P/E
N/M
Unified AI Score
50.1 / 100
HOLD
Tech 40.0
Fund 46.0
Flow 50.0
Mom 50.0
ALGN
NASDAQ
Align Technology Inc
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$155.17
-2.82% 1D
Market Cap
$11.3B
1M Return
-0.22%
1Y Return
+16.08%
Forward P/E
12.6x
Unified AI Score
40.4 / 100
SELL
Tech 20.0
Fund 47.0
Flow 68.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RBOT.WS -67.2%
ALGN +16.08%
Spread: +89.69 pp (ALGN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
RBOT.WS TTM Op. Margin: N/A
ALGN TTM Op. Margin: 19.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RBOT.WS vs ALGN. Trailing 12-month operating profitability (RBOT.WS N/A vs ALGN 19.6%) and valuation multiples (RBOT.WS N/M vs ALGN 12.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RBOT.WS | ALGN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $11.3B | Larger Scale | ALGN |
| Trailing P/E Ratio Valuation | N/M | 23.3x | Lower Multiple | ALGN |
| Forward P/E Ratio Valuation | N/M | 12.6x | Lower Multiple | ALGN |
| Revenue Growth (YoY) Growth | N/A | +1.9% | Higher Growth | ALGN |
| Operating Margin (TTM) Profitability | N/A | 19.6% | Higher Margin | ALGN |
| Net Profit Margin Profitability | N/A | 11.8% | Higher Margin | ALGN |
| Return on Equity (ROE) Capital Efficiency | N/A | 11.9% | Higher ROE | ALGN |
| 52-Week Range Position Momentum | 0% ($0โ$0) | 34% ($132โ$200) | Stronger Trend | ALGN |
| Beta / 30D Volatility Risk Regime | N/A | 1.15ฮฒ ยท 46% Vol | Lower Realized Risk | ALGN |
| Unified Institutional Score Composite Signal | 50.1 / 100 (HOLD) | 40.4 / 100 (SELL) | Higher Composite | RBOT.WS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RBOT.WS vs ALGN Buy Guide
RBOT.WS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ALGN
SURGE
9d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
10th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RBOT.WS nor ALGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.